Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
AstraZeneca
Fish and Richardson
McKesson
Medtronic
Citi
Queensland Health
Mallinckrodt

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206473

« Back to Dashboard

NDA 206473 describes LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Hospira Inc and is included in one NDA. It is available from one supplier. Additional details are available on the LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is linezolid. There are twenty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the linezolid profile page.
Summary for 206473
Tradename:LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant:Hospira Inc
Ingredient:linezolid
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 206473
Ingredient-typeOxazolidinones
Medical Subject Heading (MeSH) Categories for 206473
Suppliers and Packaging for NDA: 206473
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER linezolid SOLUTION;IV (INFUSION) 206473 NDA Hospira, Inc. 0409-4883 N 0409-4883-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;IV (INFUSION)Strength600MG/300ML (2MG/ML)
Approval Date:Jun 18, 2015TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
McKinsey
Boehringer Ingelheim
Farmers Insurance
Express Scripts
Daiichi Sankyo
AstraZeneca
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.